mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0003 |
mRNA |
Irinotecan |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0003 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0003 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0004 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.18 |
0.0004 |
mRNA |
PLX4720 |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0004 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0005 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
mRNA |
GW-2580 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0006 |